Journal Information
Vol. 47. Issue S1.
Hot topics 2010 en enfermedades respiratorias
Pages 41-45 (January 2011)
Share
Share
Download PDF
More article options
Vol. 47. Issue S1.
Hot topics 2010 en enfermedades respiratorias
Pages 41-45 (January 2011)
Full text access
Hot topics en infecciones respiratorias
Hot topics in respiratory infections
Visits
6389
M. Luiza De Souza-Galvaoa, Miguel Ángel García-Martínezb, Francisco Sanzc, José Blanquerd,
Corresponding author
blanquer_jos@gva.es

Autor para correspondencia.
a Unitat de Prevenció i Control de Tuberculosis, CAP Drassanes, Barcelona, España
b Unidad de Neumología, Hospital de Requena, Requena, Valencia, España
c Servicio de Neumología, Consorcio Hospital General Universitario de Valencia, Valencia, España
d Unidad de Cuidados Intensivos Respiratorios, Hospital Clínic Universitari de Valencia, Valencia, España
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Resumen

Se efectúa una revisión de los artículos más interesantes de infecciones respiratorias, publicados en el último trimestre del año 2009 y en 2010. En cuanto a las bronquiectasias, destacan las Guidelines de la British Thoracic Society, así como diversos artículos de la evolución natural del proceso y el impacto de las reagudizaciones de ésta, así como del tratamiento inhalatorio antibiótico de las bronquiectasias. Con respecto a la tuberculosis, es recomendable señalar el documento de consenso SEPAR-SEIMC para el manejo de la tuberculosis, así como las publicaciones sobre la utilización de interferón-gamma en el diagnóstico de infección tuberculosa. Las nuevas recomendaciones SEPAR de neumonía adquirida en la comunidad (NAC) se han publicado muy recientemente, y junto con ellas destacan estudios de etiología viral de las NAC, impacto del tratamiento corticoideo en las neumonías, duración del tratamiento antibiótico y medidas preventivas de neumonías, tanto comunitarias como nosocomiales.

Palabras clave:
Guidelines
Reagudizaciones de bronquiectasias
Interferón-gamma en diagnóstico de infección tuberculosa
Etiología viral en neumonías
Corticoides y neumonía adquirida en la comunidad
Abstract

We review the most interesting articles on respiratory infections published in the last trimester of 2009 and in 2010. Notable publications in bronchiectasis were the Guidelines of the British Thoracic Society, as well as several articles on the natural course of the process, the impact of exacerbations on the course of the disease, and treatment with inhaled antibiotics. Other notable publications were the SEPAR-SEIMC consensus document for the management of tuberculosis and articles on the use of interferon-gamma in the diagnosis of tuberculosis infection. The new recommendations of the Spanish Society of Pneumology and Thoracic Surgery on community-acquired pneumonia have recently been published. Equally important are studies on the viral etiology of community-acquired pneumonia, the impact of corticosteroid treatment in pneumonia, the duration of antibiotic therapy and preventive measures in both community-acquired and nosocomial pneumonia.

Keywords:
Guidelines
Bronchiectasis exacerbations
Interferon gamma in the diagnosis of tuberculosis infection
Viral etiology in pneumonia
Corticosteroids and community-acquired pneumonia
Full text is only aviable in PDF
Bibliografía
[1.]
M.C. Pasteur, D. Milton, A.T. Hill, on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guidelines Group.
British Thoracic Society for non-CF bronchiectasis.
Thorax, 65 (2010), pp. i1-i58
[2.]
Munro KA, Reed PW, Joyce H, et al. Do New Zeland children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pneumol. 2010 Aug 17. [Epub ahead of print].
[3.]
N. Kapur, I.B. Masters, A.B. Chang.
Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis. What influencies lung function stability?.
Chest, 138 (2010), pp. 158-164
[4.]
A.E. Seits, K.N. Olivier, C.A. Steiner, R. Montes de Oca, S.M. Holland, R. Prevots.
Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993–2006.
Chest, 138 (2010), pp. 944-949
[5.]
H.J. Roberts, R. Hubbard.
Trends in bronchiectasis mortality in England and Wales.
Respir Med, 104 (2010), pp. 981-985
[6.]
Murray MP, Govan JRW, Doherty CJ, et al. A randomized controlled trial of nebulized gentamicin in non cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2010 Sep 24. [Epub ahead of print].
[7.]
R. Dhar, G.A. Anwar, S.C. Bourke.
Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa.
[8.]
M. Palop-Cervera, A. De Diego, E. Martínez-Moragón, J. Cortijo, J. Fullana, M. León.
Estudio de marcadores de inflamación en el aire exhalado de pacientes con bronquiectasias no asociadas a fibrosis quística.
Arch Bronconeumol, 45 (2009), pp. 597-602
[9.]
Martínez-García MA, Soler-Cataluña JJ, Donat-Sanz Y, Catalán Agramunt M, Ballestín J, et al. Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients. Chest. 2010. En prensa.
[11.]
C.C. Boehme, P. Nabeta, D. Hillemann, M.P. Nicol, S. Shenai, F. Krapp, et al.
Rapid molecular detection of tuberculosis and rifampin resistance.
N Engl J Med, 363 (2010), pp. 1005-1015
[12.]
J. González-Martín, J.M. García-García, L. Anibarro, R. Vidal, J. Esteban, R. Blanquer, et al.
Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis.
Arch Bronconeumol, 46 (2010), pp. 255-274
[13.]
C.GM. Erkens, M. Kamphorst, I. Abubakar, G.H. Bothamley, D. Chemtob, W. Haas, et al.
Tuberculosis contact investigation in low prevalence countries: a European consensus.
Eur Resp J, 36 (2010), pp. 925-949
[14.]
Diel R, Goletti D, Ferrara G, Bothamley GH, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. Eur Respir J. 2010. [Epub ahead of print].
[15.]
Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J. 2010; [Epub ahead of print].
[16.]
G.R. Mazurek, J. Jereb, A. Vernon, P. Lobue, S. Goldberg, K. Castro.
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection, United States.
MMWR Recomm Rep, 59 (2010), pp. 1-26
[17.]
Canadian Tuberculosis Committee (CTC).
Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).
Can Commun Dis Rep, 34 (2008), pp. 1-13
[18.]
R. Menéndez, A. Torres, J. Aspa, A. Capelastegui, C. Prat, F. Rodríguez de Castro.
Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Arch Bronconeumol, 46 (2010), pp. 543-548
[19.]
D. Lieberman, A. Shimoni, Y. Shemer-Avni, A. Keren-Naos, R. Shtainberg, D. Lieberman.
Respiratory viruses in adults with community-acquired pneumonia.
Chest, 138 (2010), pp. 811-816
[20.]
R. Malo de Molina, E.M. Mortensen, M.I. Restrepo, L.A. Copeland, M.J.V. Pugh, A. Anzueto.
Inhaled corticosteroids use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia.
Eur Respir J, 36 (2010), pp. 751-757
[21.]
D. Snijders, J. Daniels, C.S. De Graaf, T.S. Van der Werf, W.G. Boersma, et al.
Efficacy of corticosteroids in community-acquired pneumonia. A randomized double-blinded clinical trial.
Am J Respir Crit Care, 181 (2010), pp. 975-982
[22.]
A. Davies, D. Jones, M. Bailey, J. Beca, R. Bellomo, N. Blackwell, et al.
Extracorporeal membrane oxygenation 2009 influenza A (H1N1) acute respiratory distress syndrome.
JAMA, 302 (2009), pp. 1888-1895
[23.]
S. Aliberti, F. Blasi, A.M. Zanaboni, P. Peyrani, P. Tarsia, S. Gaito, et al.
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia.
Eur Respir J, 36 (2010), pp. 128-134
[24.]
M. Falguera, A. Ruiz-González, J.A. Schoenenberger, C. Touzón, I. Gázquez, C. Galindo, et al.
Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
Thorax, 65 (2010), pp. 101-106
[25.]
G.W. Waterer, J. Rello.
Management of community-acquired pneumonia in adults.
Am J Respir Crit Care Med, (2010),
[26.]
J. Johnstone, D.T. Eurich, J.K. Minhas, T.J. Marrie, S.R. Majumdar.
Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
Clin Infect Dis, 51 (2010), pp. 15-22
[27.]
L.D. Díaz, M. Llauradó, J. Rello, M.I. Restrepo.
Prevención no farmacológica de la neumonía asociada a ventilación mecánica.
Arch Bronconeumol, 46 (2010), pp. 188-195
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?